標題: Titlebook: Biomarkers in Cardiovascular Disease; Vinood B. Patel,Victor R. Preedy Reference work 2016 Springer Science+Business Media Dordrecht 2016 [打印本頁] 作者: 近地點 時間: 2025-3-21 19:01
書目名稱Biomarkers in Cardiovascular Disease影響因子(影響力)
書目名稱Biomarkers in Cardiovascular Disease影響因子(影響力)學(xué)科排名
書目名稱Biomarkers in Cardiovascular Disease網(wǎng)絡(luò)公開度
書目名稱Biomarkers in Cardiovascular Disease網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Biomarkers in Cardiovascular Disease被引頻次
書目名稱Biomarkers in Cardiovascular Disease被引頻次學(xué)科排名
書目名稱Biomarkers in Cardiovascular Disease年度引用
書目名稱Biomarkers in Cardiovascular Disease年度引用學(xué)科排名
書目名稱Biomarkers in Cardiovascular Disease讀者反饋
書目名稱Biomarkers in Cardiovascular Disease讀者反饋學(xué)科排名
作者: 全面 時間: 2025-3-22 00:00 作者: Cocker 時間: 2025-3-22 00:41
Cardiovascular Disease Biomarkers in Clinical Use and Their Modulation by Functional Foodsion are strong risk factors for cardiovascular disease (CVD), a leading cause of morbidity and mortality worldwide. Consequently, biomarkers reflecting blood glucose, conventional lipid profiles, blood pressure, and inflammation (e.g., C-reactive protein (CRP)), that are routinely used in clinical p作者: 法官 時間: 2025-3-22 08:27
Biomarker-Guided Therapy for Chronic Heart Failuregenesis of cardiac failure, has been steadily increasing. The circulating levels of brain natriuretic peptide (BNP) and N-terminal prohormone of BNP (NT-pro-BNP) are routinely used in clinical practice to stratify the risk of patients with symptomatic chronic heart failure. This chapter discusses th作者: macular-edema 時間: 2025-3-22 12:24 作者: 總 時間: 2025-3-22 13:19
PCSK9 as a Biomarker of Cardiovascular Diseaseve to measure its concentration in blood. Circulating PCSK9 exists in several forms – its parent form and a furin-cleaved form and a low-density lipoprotein (LDL)-bound form and a free form. The furin-cleaved and LDL-bound forms are much less active. Most studies have not clearly distinguished among作者: 巨頭 時間: 2025-3-22 19:46 作者: initiate 時間: 2025-3-23 00:17 作者: 無可非議 時間: 2025-3-23 04:47 作者: 使堅硬 時間: 2025-3-23 06:02 作者: 斜谷 時間: 2025-3-23 13:41 作者: 巫婆 時間: 2025-3-23 17:46
Uncarboxylated Matrix Gla Protein as a Biomarker in Cardiovascular Disease: Applications for Researche formation of inactive MGP, also known as uncarboxylated MGP, which is set free in the blood stream where it is available for quantification by ELISA-based assays. In the healthy adult population, significant concentrations of uncarboxylated MGP are found, suggesting a widespread dietary vitamin K作者: MEEK 時間: 2025-3-23 18:25
MicroRNA-133: Biomarker and Mediator of Cardiovascular Diseasesar as recently discovered and structurally small pieces of genetic material, but we should make no mistake to underestimate these modest but powerful molecules. Regulating no less than half of the transcriptome, their influence is a key for the fine-tuning of almost any biological process. miRs are 作者: Glower 時間: 2025-3-23 23:55
Troponin Elevation Beyond Coronary Arteries high-sensitivity assays, which can detect even small increases in troponin levels, resulted in an increase in the number of patients with elevated troponin concentrations. However, in this case there are more false-positive results. This makes it of paramount importance to set differential diagnosi作者: 考古學(xué) 時間: 2025-3-24 05:07 作者: 上坡 時間: 2025-3-24 07:40
Macrophage Metalloprotease (MMP)-12 as a Cardiovascular Biomarker of CVD risk has focused the attention over the last years. Atherosclerosis (ATS) is one of the major causes of CVD. ATS is an inflammatory multifactorial disease, in which the complex interaction between immune cells and inflammatory mediators drives the growth of atherosclerotic lesions and their 作者: 萬靈丹 時間: 2025-3-24 13:47
Homocysteine as a Biomarker in Vascular Diseaser cofactors. Even a mild increase in the levels of Hcy is considered a risk factor for a number of diseases in humans, such as cardiovascular disease, stroke, neurodegenerative disorders like dementia and Alzheimer’s disease, birth defects, complicated pregnancies, and bone fractures. However, it ha作者: 有抱負者 時間: 2025-3-24 17:36 作者: 錯誤 時間: 2025-3-24 21:01 作者: 注射器 時間: 2025-3-25 01:18 作者: 摻假 時間: 2025-3-25 03:36 作者: 開花期女 時間: 2025-3-25 11:19 作者: 小隔間 時間: 2025-3-25 14:03 作者: hysterectomy 時間: 2025-3-25 18:20
Stefan Schanzenb?cher Dr. phil. provide long-term cardiovascular organ protection. In recent years, several trials have shown that drugs with promising effects on the on-target risk factor failed to improve long-term cardiovascular protection. One explanation for these failures is that a drug does not only affect the risk factor 作者: 即席演說 時間: 2025-3-25 21:38 作者: Ischemic-Stroke 時間: 2025-3-26 02:59 作者: 畢業(yè)典禮 時間: 2025-3-26 04:25
https://doi.org/10.1007/978-3-322-97602-4ase, heart disease associated with pressure overload, heart disease associated with volume overload, and intrinsic myocardial disease or cardiomyopathy. Collagen, types I and III, is the principal structural protein found in the myocardium, and its pro- or telopeptides are released into the circulat作者: overbearing 時間: 2025-3-26 09:25
Michael Stiels-Glenn,Penelope Glennve to measure its concentration in blood. Circulating PCSK9 exists in several forms – its parent form and a furin-cleaved form and a low-density lipoprotein (LDL)-bound form and a free form. The furin-cleaved and LDL-bound forms are much less active. Most studies have not clearly distinguished among作者: Estrogen 時間: 2025-3-26 14:36 作者: reject 時間: 2025-3-26 17:26
https://doi.org/10.1007/978-3-662-12178-8ent functions in human physiology and pathophysiology. Most studies suggest a biphasic effect of fetuin-A depending on the stages of atherosclerosis. Serum levels of fetuin-A are decreased in cases of acute inflammation. Therefore, it is known as a negative acute-phase protein. Fetuin-A inhibits ins作者: Phonophobia 時間: 2025-3-27 00:57
Pyelonephritis und Nierendysplasie,nce. Acetylcholine is the main parasympathetic neurotransmitter, involved in restoring hemostasis, reducing heart rate, and blocking inflammation and anxiety. Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), the acetylcholine-hydrolyzing enzymes, can be detected via reliable, low-cost m作者: 結(jié)構(gòu) 時間: 2025-3-27 02:37 作者: 漂亮才會豪華 時間: 2025-3-27 06:12
Diabetes insipidus neurohormonalis,admissions. Better triaging of patients with suspected ACS is needed to facilitate early initiation of appropriate therapy in patients with acute myocardial infarction and to exclude low-risk patients who can safely be sent home thereby limiting healthcare costs. Heart-type fatty acid-binding protei作者: 荒唐 時間: 2025-3-27 11:56
Die kongenitale Alkalose mit Diarrhoe,he formation of inactive MGP, also known as uncarboxylated MGP, which is set free in the blood stream where it is available for quantification by ELISA-based assays. In the healthy adult population, significant concentrations of uncarboxylated MGP are found, suggesting a widespread dietary vitamin K作者: 情感脆弱 時間: 2025-3-27 15:01 作者: cochlea 時間: 2025-3-27 18:46 作者: 讓你明白 時間: 2025-3-28 00:33
Prognose der kongenitalen Syphilis,rowth factors with pronounced angiopoetic capacity in vivo. VEGF-1 is expressed in tissue due to hypoxia and inflammation by wide spectrum of the cells and contributes angiogenesis and neovascularization by several mechanisms. A paracrine regulation of the VEGF-1 activity is mediated by a specific s作者: 退潮 時間: 2025-3-28 03:42 作者: restrain 時間: 2025-3-28 08:21
Konglomerate Unternehmensdiversifikationr cofactors. Even a mild increase in the levels of Hcy is considered a risk factor for a number of diseases in humans, such as cardiovascular disease, stroke, neurodegenerative disorders like dementia and Alzheimer’s disease, birth defects, complicated pregnancies, and bone fractures. However, it ha作者: 委屈 時間: 2025-3-28 13:29
Die kongenitale Alkalose mit Diarrhoe,or cardiovascular disease and mortality, and total uncarboxylated MGP (t-ucMGP), a disease marker for prevalent arterial calcification. The assay principles and the diagnostic utility of both markers are described in this chapter.作者: SLAG 時間: 2025-3-28 17:24 作者: Host142 時間: 2025-3-28 22:45
Reference work 2016ion have identified cardiovascular disease as the leading cause of death worldwide.? Although many cardiovascular conditions are preventable, there is a need for accurate characterisation and diagnosis of cardiovascular conditions before, during and after treatments. Much of this characterisation en作者: vertebrate 時間: 2025-3-29 00:12
2542-3657 Points..Wide applicability with each chapter containing a sOn an annual basis, over 17 million people die due to cardiovascular disease. This represents a third of all global deaths. The World Health Organisation have identified cardiovascular disease as the leading cause of death worldwide.? Altho作者: 枯燥 時間: 2025-3-29 03:38
Stefan Schanzenb?cher Dr. phil.of this chapter is to examine biomarkers relevant to cardiovascular diseases in order to identify targets where pharmacological treatment can act. In this chapter, we will examine the main markers of insulin resistance, inflammation, endothelial damage, and metabolism linked to cardiovascular diseases.作者: 大看臺 時間: 2025-3-29 10:54
Testing Pharmacological Profiles with Biomarkers Relevant to Cardiovascular Profilesof this chapter is to examine biomarkers relevant to cardiovascular diseases in order to identify targets where pharmacological treatment can act. In this chapter, we will examine the main markers of insulin resistance, inflammation, endothelial damage, and metabolism linked to cardiovascular diseases.作者: 脆弱吧 時間: 2025-3-29 11:34 作者: 撫慰 時間: 2025-3-29 18:48 作者: 驚惶 時間: 2025-3-29 22:19 作者: 嘮叨 時間: 2025-3-30 03:35
Diabetes insipidus neurohormonalis,P identifies patients at increased risk for future cardiac events. It is concluded that measuring H-FABP along with troponin shortly after onset of symptoms improves risk stratification of patients suspected of having ACS in a cost-effective manner.作者: photophobia 時間: 2025-3-30 07:58
Circulating Vasoactive Peptide Urotensin II and Relationships with Cardiovascular Diseasees of urotensin II and urotensin II-related peptide in the cardiovascular system, with particular emphasis on the implications in cardiovascular disease and the potential application of UII as a disease biomarker.作者: 使人煩燥 時間: 2025-3-30 10:41
Serum Cholinesterase Activities as Biomarkers of Cardiac Malfunctioningtivities beyond the normal range are at risk for non-survival or poor recovery outcome following stroke or myocardial infarction. In this chapter, we will introduce the ChEs, the detection methods available for measuring their activities, and the relevant studies validating the roles of ChEs as risk factors for cardiovascular diseases.作者: 檔案 時間: 2025-3-30 13:51
Biomarkers of Myocardial Cell Damage: Heart-Type Fatty Acid Binding Protein (H-FABP) for the Early EP identifies patients at increased risk for future cardiac events. It is concluded that measuring H-FABP along with troponin shortly after onset of symptoms improves risk stratification of patients suspected of having ACS in a cost-effective manner.作者: Wordlist 時間: 2025-3-30 17:10
Use of Multiple Biomarkers to Estimate Cardiovascular Drug Efficacy: Advantage of a PRE Scoreisk management. Keynote in this chapter is that ignoring off-target effects of a drug may lead to severe misinterpretations about the long-term cardiovascular protective effect, with major consequences for society and individual patients. To solve this problem, all effects of a drug should be incorp作者: 平淡而無味 時間: 2025-3-31 00:11 作者: municipality 時間: 2025-3-31 03:13 作者: nullify 時間: 2025-3-31 08:09 作者: surrogate 時間: 2025-3-31 10:06
PCSK9 as a Biomarker of Cardiovascular Diseasein women than men, and higher after menopause. In male adolescents, it decreases with age, while in female adolescents, it increases with age. It is elevated in pregnancy at term, and umbilical cord blood has lower serum PCSK9 levels than maternal blood. Ideally, measurement of plasma PCSK9 should b作者: follicle 時間: 2025-3-31 17:24 作者: resuscitation 時間: 2025-3-31 20:00
Triglycerides (TG) to High-Density Lipoprotein (HDL-c) Ratio (TG/HDL-c Ratio) as a Marker of Cardiomvidences demonstrated the TG/HDL-c ratio is well related not only with current cardio-metabolic diseases, but it seems to be able to predict the risk to develop cardiovascular accidents..The goal of this book chapter is to describe the potential role of TG/HDL-c ratio as a marker to evaluate and to 作者: Infuriate 時間: 2025-3-31 23:41
